-
EP2164843
European procedure
Extract from the Register of European Patents
EP About this file: EP2164843
| EP2164843 - PYRIDAZINONE DERIVATES [Right-click to bookmark this link] | |||
| Former [2010/12] | PYRIDAZINONE DERIVATES | ||
| [2014/44] | Status | No opposition filed within time limit Status updated on 04.09.2015 Database last updated on 31.03.2026 | Most recent event Tooltip | 04.09.2015 | No opposition filed within time limit | published on 07.10.2015 [2015/41] | Applicant(s) | For all designated states Merck Patent GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | [2010/12] | Inventor(s) | 01 /
DORSCH, Dieter Königsberger Strasse 17A 64372 Ober-Ramstadt / DE | 02 /
STIEBER, Frank Max-Reger-Strasse 16 69121 Heidelberg / DE | 03 /
SCHADT, Oliver Forststrasse 4 63517 Rodenbach / DE | 04 /
BLAUKAT, Andree Branichstrasse 9 69198 Schriesheim / DE | [2010/18] |
| Former [2010/12] | 01 /
DORSCH, Dieter Königsberger Strasse 17A 64372 Ober-Ramstadt / DE | ||
| 02 /
STIEBER, Frank Max-Reger-Strasse 16 69121 Heidelberg / DE | |||
| 03 /
SCHADT, Oliver Forststrasse 4 63517 Rodenbach / DE | |||
| 04 /
BLAUKAT, Andree Am Klingenteich 17a 64367 Muehltal / DE | Application number, filing date | 08758359.7 | 29.04.2008 | [2014/44] | WO2008EP03473 | Priority number, date | DE20071032507 | 12.07.2007 Original published format: DE102007032507 | [2010/12] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2009006959 | Date: | 15.01.2009 | Language: | DE | [2009/03] | Type: | A1 Application with search report | No.: | EP2164843 | Date: | 24.03.2010 | Language: | DE | The application published by WIPO in one of the EPO official languages on 15.01.2009 takes the place of the publication of the European patent application. | [2010/12] | Type: | B1 Patent specification | No.: | EP2164843 | Date: | 29.10.2014 | Language: | DE | [2014/44] | Search report(s) | International search report - published on: | EP | 15.01.2009 | Classification | IPC: | C07D401/14, C07D405/14, C07D413/14, C07D403/14, C07D413/10, C07D417/10, C07D401/10, C07D403/10, C07D409/14, C07D417/14, C07D451/06, C07D453/02, A61K45/06, A61K31/501, A61K31/506, A61K31/55, A61K31/5355, A61K31/5377 | [2014/07] | CPC: |
C07D403/10 (EP,US);
A61K31/501 (EP,US);
A61K31/506 (EP,US);
A61K31/5355 (EP,US);
A61K31/5377 (EP,US);
A61K31/55 (EP,US);
A61K45/06 (EP,US);
A61K47/02 (EP,US);
A61K9/0014 (EP,US);
A61K9/0019 (EP,US);
A61K9/0031 (EP,US);
A61K9/0048 (EP,US);
A61K9/02 (EP,US);
A61K9/06 (EP,US);
A61K9/08 (EP,US);
A61K9/2018 (EP,US);
A61P1/16 (EP);
A61P13/12 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P9/10 (EP);
A61P9/14 (EP);
C07D401/10 (EP,US);
C07D401/14 (EP,US);
C07D403/14 (EP,US);
C07D405/14 (EP,US);
C07D409/14 (EP,US);
C07D413/10 (EP,US);
C07D413/14 (EP,US);
C07D417/10 (EP,US);
C07D417/14 (EP,US);
C07D451/06 (EP,US);
C07D453/02 (EP,US);
| C-Set: |
A61K31/501, A61K2300/00 (US,EP);
A61K31/506, A61K2300/00 (EP,US);
A61K31/5355, A61K2300/00 (EP,US);
A61K31/5377, A61K2300/00 (US,EP); |
| Former IPC [2010/12] | C07D403/14, C07D413/10, C07D417/10, C07D413/14 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/12] | Title | German: | PYRIDAZINONDERIVATE | [2014/44] | English: | PYRIDAZINONE DERIVATES | [2014/44] | French: | DÉRIVÉS DE PYRIDAZINONE | [2014/44] |
| Former [2010/12] | PYRIDAZINONDERIVATE | ||
| Former [2010/12] | PYRIDAZINONE DERIVATES | ||
| Former [2010/12] | DÉRIVÉS DE PYRIDAZINONE | Entry into regional phase | 11.11.2009 | National basic fee paid | 11.11.2009 | Designation fee(s) paid | 11.11.2009 | Examination fee paid | Examination procedure | 11.11.2009 | Examination requested [2010/12] | 27.04.2010 | Despatch of a communication from the examining division (Time limit: M04) | 26.07.2010 | Reply to a communication from the examining division | 07.02.2011 | Despatch of a communication from the examining division (Time limit: M04) | 28.04.2011 | Reply to a communication from the examining division | 20.12.2011 | Despatch of a communication from the examining division (Time limit: M04) | 08.03.2012 | Reply to a communication from the examining division | 04.02.2014 | Communication of intention to grant the patent | 10.04.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 26.06.2014 | Communication of intention to grant the patent | 15.09.2014 | Fee for grant paid | 15.09.2014 | Fee for publishing/printing paid | 15.09.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | EP14001269.1 / EP2754660 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.04.2010 | Opposition(s) | 30.07.2015 | No opposition filed within time limit [2015/41] | Fees paid | Renewal fee | 25.03.2010 | Renewal fee patent year 03 | 12.04.2011 | Renewal fee patent year 04 | 30.03.2012 | Renewal fee patent year 05 | 12.04.2013 | Renewal fee patent year 06 | 25.03.2014 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | by applicant | WO2007065518 | DE19604388 | WO03037349 | WO2007057093 | WO2007057092 | EP1043317 | EP1061077 | EP0738716 | EP0711759 | US4397854 | JPS5795964 | WO2007075567 | WO9722596 | WO9730035 | WO9732856 | WO9813354 | WO9902166 | WO0040529 | WO0041669 | WO0192224 | WO0204434 | WO0208213 | WO03104225 | DE10010422 | US3853946 | WEINSTEIN-OPPENHEIMER ET AL., PHARMA. &. THERAP., vol. 88, 2000, pages 229 - 279 | S. BERTHOU ET AL., ONCOGENE, vol. 23, no. 31, 2004, pages 5387 - 5393 | J.G. CHRISTENSEN ET AL., CANCER RES., vol. 63, no. 21, 2003, pages 7345 - 55 | H. HOV ET AL., CLINICAL CANCER RESEARCH, vol. 10, 2004, pages 6686 - 6694 | KHWAJA ET AL., EMBO, vol. 16, 1997, pages 2783 - 93 | WHITE ET AL., ONCOGENE, vol. 20, 2001, pages 7064 - 7072 | STEPHENS ET AL., BIOCHEMICAL J., vol. 351, 2000, pages 95 - 105 | ALESSI ET AL., FEBS, vol. 399, no. 3, 1996, pages 333 - 338 | CAMPOS-GONZLEZ, R.; GLENNEY, JR., J.R., J. BIOL. CHEM., vol. 267, 1992, pages 14535 | SORG ET AL., J. OF. BIOMOLECULAR SCREENING, vol. 7, 2002, pages 11 - 19 | SILLS ET AL., J. OF BIOMOLECULAR SCREENING, 2002, pages 191 - 214 | ROSS ET AL., BIOCHEM. J., 2002 | INT. J. PHARM., vol. 115, 1995, pages 61 - 67 | W. J. COATES; A. MCKILLOP, SYNTHESIS, 1993, pages 334 - 342 | PHARMACEUTICAL RESEARCH, vol. 3, no. 6, 1986, pages 318 | DHANABAL ET AL., CANCER RES., vol. 59, pages 189 - 197 | XIN ET AL., J. BIOL. CHEM., vol. 274, pages 9116 - 9121 | SHEU ET AL., ANTICANCER RES., vol. 18, pages 4435 - 4441 | AUSPRUNK ET AL., DEV. BIOL., vol. 38, pages 237 - 248 | GIMBRONE ET AL., J. NATL. CANCER INST., vol. 52, pages 413 - 427 | NICOSIA ET AL., IN VITRO, vol. 18, pages 538 - 549 | W. H. COATES; A. MCKILLOP, SYNTHESIS, 1993, pages 334 | A. J. GOODMAN ET AL., TETRAHEDRON, vol. 55, 1999, pages 15067 - 15070 | EUR. J. MED. CHEM., vol. 27, 1992, pages 545 - 549 | W. W. K. R. MEDERSKI ET AL., TETRAHEDRON, vol. 55, 1999, pages 12757 - 12770 | P. J. COLEMAN ET AL., J. MED. CHEM., vol. 47, 2004, pages 4829 - 4837 | S.H. BERZ ET AL., JOURNAL OF ORGANIC CHEMISTRY, vol. 47, 1982, pages 2216 |